HMS Capital Management LLC reduced its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 4.0% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 6,169 shares of the medical research company’s stock after selling 260 shares during the period. Thermo Fisher Scientific comprises approximately 1.2% of HMS Capital Management LLC’s portfolio, making the stock its 13th biggest holding. HMS Capital Management LLC’s holdings in Thermo Fisher Scientific were worth $2,815,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also modified their holdings of the business. Annapolis Financial Services LLC bought a new position in shares of Thermo Fisher Scientific in the fourth quarter worth approximately $26,000. ShoreHaven Wealth Partners LLC bought a new position in shares of Thermo Fisher Scientific in the fourth quarter worth approximately $28,000. Dimension Capital Management LLC bought a new position in shares of Thermo Fisher Scientific in the third quarter worth approximately $31,000. Larson Financial Group LLC grew its holdings in shares of Thermo Fisher Scientific by 38.5% in the fourth quarter. Larson Financial Group LLC now owns 72 shares of the medical research company’s stock worth $34,000 after purchasing an additional 20 shares during the last quarter. Finally, Oder Investment Management LLC bought a new position in shares of Thermo Fisher Scientific in the fourth quarter worth approximately $34,000. Institutional investors and hedge funds own 87.17% of the company’s stock.
A number of analysts recently commented on the company. Credit Suisse Group raised their price target on Thermo Fisher Scientific from $556.00 to $580.00 in a research note on Tuesday, January 12th. BTIG Research raised their price target on Thermo Fisher Scientific from $540.00 to $590.00 and gave the stock a “buy” rating in a research note on Wednesday, February 3rd. UBS Group dropped their price target on Thermo Fisher Scientific from $588.00 to $560.00 and set a “buy” rating for the company in a research note on Monday, March 29th. Smith Barney Citigroup lowered Thermo Fisher Scientific from a “buy” rating to a “neutral” rating in a research note on Wednesday, December 16th. Finally, SVB Leerink raised their price target on Thermo Fisher Scientific from $525.00 to $560.00 and gave the stock an “outperform” rating in a research note on Tuesday, February 2nd. Four analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $524.45.
Shares of TMO traded down $2.52 during trading hours on Monday, hitting $476.36. The company had a trading volume of 38,365 shares, compared to its average volume of 1,817,991. The firm has a fifty day moving average price of $455.25 and a 200-day moving average price of $471.29. The company has a debt-to-equity ratio of 0.66, a quick ratio of 2.31 and a current ratio of 2.93. The stock has a market capitalization of $187.59 billion, a price-to-earnings ratio of 39.25, a P/E/G ratio of 1.40 and a beta of 0.85. Thermo Fisher Scientific Inc. has a 52-week low of $309.18 and a 52-week high of $532.57.
Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings results on Sunday, January 31st. The medical research company reported $7.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.56 by $0.53. The firm had revenue of $10.55 billion during the quarter, compared to analyst estimates of $9.53 billion. Thermo Fisher Scientific had a return on equity of 21.35% and a net margin of 17.12%. Thermo Fisher Scientific’s quarterly revenue was up 54.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $3.55 EPS. Research analysts anticipate that Thermo Fisher Scientific Inc. will post 19.03 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 16th. Investors of record on Tuesday, March 16th will be issued a $0.26 dividend. This represents a $1.04 annualized dividend and a yield of 0.22%. This is an increase from Thermo Fisher Scientific’s previous quarterly dividend of $0.22. The ex-dividend date of this dividend is Monday, March 15th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is presently 8.42%.
Thermo Fisher Scientific Profile
Thermo Fisher Scientific Inc offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
See Also: How to Invest in an Index Fund